Hydrazine

Hydrazine

SCHEMBL2350819

[2H]NN

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrazine SCHEMBL4096587 0.80
Hydrazine SCHEMBL9443194 0.63
Hydrazine SCHEMBL8158007 0.63
Hydrazine SCHEMBL8141972 0.63
Hydrazine SCHEMBL2463370 0.63
Hydrazine SCHEMBL239 0.63
Hydrazine SCHEMBL16089343 0.63
Hydrazine SCHEMBL13889965 0.60
Hydroxyamine SCHEMBL9120526 0.55
Hydrazine SCHEMBL23797207 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3861037-B1 RESIN COMPOSITION CUBICURE GMBH (AT) 2022-10-19 EP claimed
CN-101742995-A detecting succinylacetone PERKINELMER LAS INC 2010-06-16 CN claimed
US-4157270-A FOR USE IN DEUTERIUM FLUORIDE OR HYDROGEN FLUORIDE LASERS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1979-06-05 US claimed
US-3987590-A Methods of fabricating thermonuclear fuel elements UNIVERSITY OF ROCHESTER (US) 1976-10-26 US claimed
WO-2025040142-A1 METHOD FOR MEASURING CONTENT OF HYDRAZINE IN CARBIDOPA-CONTAINING DRUG 上海汉都医药科技有限公司 2025-02-27 WO disclosed
EP-4453080-A1 PROCESS FOR PREPARING POLYBUTENE COMPOSITIONS HAVING INCREASED CRYSTALLIZATION TEMPERATURE Basell Poliolefine Italia S.r.l. (IT) 2024-10-30 EP disclosed
US-12037324-B2 Biarylmethyl heterocycles BRISTOL-MYERS SQUIBB COMPANY (US) 2024-07-16 US disclosed
CN-117440832-A Antibody-drug conjugates comprising anti-BCMA antibodies 索伦托药业有限公司 2024-01-23 CN disclosed
EP-4247796-A1 PROCESS FOR THE PREPARATION OF PROTHIOCONAZOLE AND INTERMEDIATES THEREOF ADAMA MAKHTESHIM LTD. (IL) 2023-09-27 EP disclosed
WO-2022107139-A1 PROCESS FOR THE PREPARATION OF PROTHIOCONAZOLE AND INTERMEDIATES THEREOF ADAMA MAKHTESHIM LTD. (IL) 2022-05-27 WO disclosed
CN-111718307-A Preparation method of deuterated 1, 5-diaminotetrazole 北京理工大学 2020-09-29 CN disclosed
US-9434747-B2 Methods of treating diabetes MEDIVATION TECHNOLOGIES, INC. (US) 2016-09-06 US disclosed
WO-1997019039-A1 SOLID PHASE SYNTHESIS OF HETEROCYCLIC COMPOUNDS AND COMBINATORIAL COMPOUND LIBRARY NOVARTIS AG (CH) 1997-05-29 WO disclosed
EP-0327223-B1 ANXIOLYTIC AND ANTIDEPRESSANT TETRAHYDROBENZOTHIENOPYRIDINE DERIVATIVES BEECHAM GROUP PLC (GB) 1993-06-02 EP disclosed
US-5093493-A Anxiolytic agents, antidepressants BEECHAM GROUP P.L.C. (GB) 1992-03-03 US disclosed
EP-0327223-A1 Anxiolytic and antidepressant tetrahydrobenzothienopyridine derivatives BEECHAM GROUP PLC (GB) 1989-08-09 EP disclosed
CN-1034539-A The preparation method of hydrazides and hydroxamic acid derivs SANDOZ LTD (CH) 1989-08-09 CN disclosed
US-4157270-A FOR USE IN DEUTERIUM FLUORIDE OR HYDROGEN FLUORIDE LASERS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1979-06-05 US disclosed
US-4157270-A FOR USE IN DEUTERIUM FLUORIDE OR HYDROGEN FLUORIDE LASERS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1979-06-05 US disclosed
US-3987590-A Methods of fabricating thermonuclear fuel elements UNIVERSITY OF ROCHESTER (US) 1976-10-26 US disclosed